Independent Panel to Advise Against Low-Dose Aspirin Regimen to Prevent Heart Attacks

October 12, 2021 by Dan McCue
Independent Panel to Advise Against Low-Dose Aspirin Regimen to Prevent Heart Attacks
An arrangement of aspirin pills. (AP Photo/Patrick Sison)

WASHINGTON — The longstanding recommendation that older individuals start taking a low-dose aspirin to stave off a potential first heart attack or stroke was wrong, according to draft guidelines released Tuesday by the U.S. Preventive Services Task Force 

The proposal from the task force, an independent, volunteer panel of national experts in disease prevention and evidence-based medicine, is based on its finding that the risk of serious side effects, like bleeding in the stomach, intestines, and brain, far outweighs the potential benefits.

Heart disease and stroke continue to be leading causes of mortality in the United States, accounting for about one in three deaths, the Task Force said.

“While daily aspirin use has been shown to lower the chance of having a first heart attack or stroke … the chance of bleeding increases with age and can be life-threatening,” the panel said.

“Based on new evidence … it is now recommended that once people turn 60 years old,  they should not consider starting to take aspirin because the risk of bleeding cancels out the benefits of preventing heart disease,” it said.

This recommendation only applies to people who are at higher risk for cardiovascular disease, have no history of it, and are not already taking daily aspirin.

When deciding whether patients should start taking aspirin to prevent a first heart attack or stroke, the panel recommends that clinicians consider age, heart disease risk, and bleeding risk. 

If an individual is already taking aspirin and has any questions, the task force recommends they talk to their clinician about their individual circumstances.

“The latest evidence is clear: starting a daily aspirin regimen in people who are 60 or older to prevent a first heart attack or stroke is not recommended,” said Dr. Chien-Wen Tseng, a task force member, in a written statement. “However, this task force recommendation is not for people already taking aspirin for a previous heart attack or stroke; they should continue to do so unless told otherwise by their clinician.”

The findings are a little different when it comes to people aged 40 to 59 who have been deemed to be at a higher risk of cardiovascular diseases.

“The latest information … shows a closer balance of benefits and harms than previously understood for people in their 50s and that starting aspirin use as young as 40 years old may have some benefit.”

Dr. John Wong, a member of the task force, said in a written statement said in light of the panel’s new findings, “It’s important that people who are 40 to 59 years old and don’t have a history of heart disease have a conversation with their clinician to decide together if starting to take aspirin is right for them.”

A+
a-
  • aspirin
  • heart attacks
  • strokes
  • US PReventive Services Task FOrce
  • In The News

    Health

    Voting

    Health

    What Do Weight Loss Drugs Mean for a Diet Industry Built on Eating Less and Exercising More?

    NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds... Read More

    NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept... Read More

    April 24, 2024
    by Dan McCue
    First Lady Jill Biden Salutes ‘The Power of Research’ at DC Symposium

    WASHINGTON — Even years after the fact, First Lady Dr. Jill Biden recalled the moment with a sense of astonished... Read More

    WASHINGTON — Even years after the fact, First Lady Dr. Jill Biden recalled the moment with a sense of astonished disbelief. Biden was second lady, the wife of Vice President Joe Biden, at the time, and Maria Shriver was the first lady of California.  Both were... Read More

    April 24, 2024
    by Dan McCue
    FDA Approves New Treatment for Urinary Tract Infections

    WASHINGTON — The Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary... Read More

    WASHINGTON — The Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections.  “Uncomplicated UTIs are a very common condition impacting women and one of the most frequent reasons for antibiotic use,” said Dr. Peter Kim, M.S.,... Read More

    When Red-Hot Isn't Enough: New Heat Risk Tool Sets Magenta as Most Dangerous Level

    WASHINGTON (AP) — Forget about red hot. A new color-coded heat warning system relies on magenta to alert Americans to... Read More

    WASHINGTON (AP) — Forget about red hot. A new color-coded heat warning system relies on magenta to alert Americans to the most dangerous conditions they may see this summer. The National Weather Service and the Centers for Disease Control and Prevention on Monday — Earth Day... Read More

    April 23, 2024
    by Dan McCue
    President Lays Out New Steps for Protecting Nation’s Waters

    WASHINGTON — The Biden administration on Tuesday set out a new national goal for conserving and restoring the United States’... Read More

    WASHINGTON — The Biden administration on Tuesday set out a new national goal for conserving and restoring the United States’ freshwater resources, including 8 million acres of wetlands and 100,000 miles of rivers and streams. Officials unveiled the plan as state, tribal and local leaders from... Read More

    April 23, 2024
    by Beth McCue
    Study Finds Next-Gen Antibiotics Underutilized

    WASHINGTON — A new study conducted by researchers at the National Institutes of Health found clinicians frequently continue to treat... Read More

    WASHINGTON — A new study conducted by researchers at the National Institutes of Health found clinicians frequently continue to treat antibiotic-resistant infections with older generic antibiotics considered to be less effective and less safe than newer ones. Researchers examined the factors influencing doctors’ preference for older... Read More

    News From The Well
    scroll top